Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats ; volume:14 ; number:1 ; day:2 ; month:5 ; year:2015 ; pages:1-6 ; date:12.2015
Lipids in health and disease ; 14, Heft 1 (2.5.2015), 1-6, 12.2015
- Creator
-
Zheng, Dongdan
Liang, Qing
Zeng, FanFang
Mai, Zhuocheng
Cai, Anping
Qiu, Ruofeng
Xu, Rulin
Li, Dongjuan
Mai, Weiyi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-015-0041-2
- URN
-
urn:nbn:de:101:1-2021082619421173598254
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zheng, Dongdan
- Liang, Qing
- Zeng, FanFang
- Mai, Zhuocheng
- Cai, Anping
- Qiu, Ruofeng
- Xu, Rulin
- Li, Dongjuan
- Mai, Weiyi
- SpringerLink (Online service)
Other Objects (12)
Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia
Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function
Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
Diabetes Dyslipidemia
FAT10 protects against ischemia-induced ventricular arrhythmia by decreasing Nedd4-2/Nav1.5 complex formation
Impact of LDLR polymorphisms on lipid levels and atorvastatin’s efficacy in a northern Chinese adult Han cohort with dyslipidemia
Worldwide Dyslipidemia Guidelines
5.1 Enhanced Communication Via Gap Junctions Protects the Endothelium from Ischaemia-Reperfusion Injury in Vivo in Man
A Formal Synthesis of Atorvastatin
Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia
Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function
Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
Diabetes Dyslipidemia
FAT10 protects against ischemia-induced ventricular arrhythmia by decreasing Nedd4-2/Nav1.5 complex formation
Impact of LDLR polymorphisms on lipid levels and atorvastatin’s efficacy in a northern Chinese adult Han cohort with dyslipidemia
Worldwide Dyslipidemia Guidelines
5.1 Enhanced Communication Via Gap Junctions Protects the Endothelium from Ischaemia-Reperfusion Injury in Vivo in Man
A Formal Synthesis of Atorvastatin
Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia
Atorvastatin combined with poly-unsaturated fatty acid confers better improvement of dyslipidemia and endothelium function
Hypertension and Dyslipidemia: the Two Partners in Endothelium-Related Crime
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial
Diabetes Dyslipidemia
FAT10 protects against ischemia-induced ventricular arrhythmia by decreasing Nedd4-2/Nav1.5 complex formation
Impact of LDLR polymorphisms on lipid levels and atorvastatin’s efficacy in a northern Chinese adult Han cohort with dyslipidemia
Worldwide Dyslipidemia Guidelines
5.1 Enhanced Communication Via Gap Junctions Protects the Endothelium from Ischaemia-Reperfusion Injury in Vivo in Man